Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
As further described under Item 5.07 of this Current Report on Form 8-K (this “Form 8-K”), at the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of PepGen Inc. (the “Company”), and upon the recommendation of the Board of Directors of the Company (the “Board”), the Company’s stockholders approved a Certificate of Amendment to the Company’s Third Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by recent amendments to Delaware law (the “Officer Exculpation Amendment”). The Officer Exculpation Amendment was previously approved by the Board, subject to stockholder approval.
The Officer Exculpation Amendment is described in detail under “PROPOSAL NO. 2 – APPROVAL OF AN AMENDMENT TO OUR THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION” beginning on page 15 of the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 26, 2024 (the “Proxy Statement”) in connection with the 2024 Annual Meeting. The text of the Officer Exculpation Amendment is included on page 15 of the Proxy Statement.
The Officer Exculpation Amendment became effective upon its filing with the Secretary of State of the State of Delaware on June 20, 2024.
The foregoing description of the Officer Exculpation Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Officer Exculpation Amendment, a copy of which is filed as Exhibit 3.1 to this Form 8-K and incorporated herein by reference.
Item 5.07 | Submission of Matters to a Vote of Security Holders. |
The Company’s 2024 Annual Meeting was held on June 20, 2024. The proposals set forth below were submitted to the stockholders at the 2024 Annual Meeting, with each such proposal described in the Proxy Statement.
The number of shares of common stock entitled to vote at the 2024 Annual Meeting was 32,390,445. The number of shares of common stock present or represented by valid proxy at the 2024 Annual Meeting was 30,365,425. Therefore, a quorum was present. The number of votes cast for and withheld/against and the number of abstentions and broker non-votes with respect to each proposal voted upon are set forth below.
Proposal 1 - Election of Directors
The Company’s stockholders elected the two Class II directors to the Company’s Board, to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal.
| | | | | | | | |
Director Nominee | | Votes For | | | Votes Withheld | |
Habib Dable | | | 26,048,824 | | | | 2,675,212 | |
James McArthur, Ph.D. | | | 29,411,307 | | | | 19,804 | |
There were 1,641,389 broker non-votes regarding the election of Habib Dable and there were 934,314 broker non-votes regarding the election of James McArthur.
Proposal 2 – Approval of Amendment to Company’s Third Amended and Restated Certificate of Incorporation
The Company’s stockholders approved the Officer Exculpation Amendment described above to limit the liability of certain officers of the Company as permitted by recent amendments to Delaware law.
| | | | |
Votes For | | Votes Against | | Abstentions |
29,397,027 | | 34,068 | | 114 |
There were 934,216 broker non-votes regarding this proposal.